These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


112 related items for PubMed ID: 9820082

  • 1. [Steroid osteoporosis].
    Kocián J.
    Vnitr Lek; 1998 Feb; 44(2):86-92. PubMed ID: 9820082
    [Abstract] [Full Text] [Related]

  • 2. Anabolic steroids in corticosteroid-induced osteoporosis.
    Adami S, Rossini M.
    Wien Med Wochenschr; 1993 Feb; 143(14-15):395-7. PubMed ID: 8256456
    [Abstract] [Full Text] [Related]

  • 3. [Disorders of bone mineralization and their treatment in Crohn's disease].
    Kocián J, Kociánová J.
    Vnitr Lek; 1998 Mar; 44(3):162-5. PubMed ID: 9820096
    [Abstract] [Full Text] [Related]

  • 4. Effect of long-term calcitonin administration on steroid-induced osteoporosis after cardiac transplantation.
    Kapetanakis EI, Antonopoulos AS, Antoniou TA, Theodoraki KA, Zarkalis DA, Sfirakis PD, Chilidou DA, Alivizatos PA.
    J Heart Lung Transplant; 2005 May; 24(5):526-32. PubMed ID: 15896748
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of patients with postmenopausal osteoporosis and steroid-induced osteoporosis with the preparation Rocaltrol (1,25/OH/2 vitamin D3)].
    Koev D, Todorova S, Diankov L, Khristova D, Tsachev K.
    Vutr Boles; 1988 May; 27(2):117-22. PubMed ID: 3414094
    [Abstract] [Full Text] [Related]

  • 6. [Post-steroidal osteoporosis].
    Drozdzowska B, Pluskiewicz W.
    Przegl Lek; 1999 May; 56(2):157-60. PubMed ID: 10375951
    [Abstract] [Full Text] [Related]

  • 7. [Prevalence of steroid osteoporosis].
    Mori S.
    Clin Calcium; 2006 Nov; 16(11):1782-7. PubMed ID: 17079843
    [Abstract] [Full Text] [Related]

  • 8. [New data on the pathogenesis of steroid-induced osteoporosis: consequences for therapy and prevention].
    Hüfner M, Siggelkow H.
    Dtsch Med Wochenschr; 2003 Jul 25; 128(30):1602-8. PubMed ID: 12884149
    [No Abstract] [Full Text] [Related]

  • 9. [Glucocorticoid-induced osteoporosis].
    Tóth M, Tulassay Z.
    Orv Hetil; 2000 Jan 30; 141(5):219-23. PubMed ID: 10697979
    [Abstract] [Full Text] [Related]

  • 10. Effect of calcitriol on bone mineral density in premenopausal Chinese women taking chronic steroid therapy. A randomized, double blind, placebo controlled study.
    Lambrinoudaki I, Chan DT, Lau CS, Wong RW, Yeung SS, Kung AW.
    J Rheumatol; 2000 Jul 30; 27(7):1759-65. PubMed ID: 10914864
    [Abstract] [Full Text] [Related]

  • 11. [Pathogenesis of corticoid-induced osteoporosis].
    Ringe JD.
    Fortschr Med; 1990 Jul 10; 108(20):393-6. PubMed ID: 2202618
    [Abstract] [Full Text] [Related]

  • 12. Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis.
    Brixen KT, Christensen PM, Ejersted C, Langdahl BL.
    Basic Clin Pharmacol Toxicol; 2004 Jun 10; 94(6):260-70. PubMed ID: 15228497
    [Abstract] [Full Text] [Related]

  • 13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 10; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 14. Prevention of corticosteroid induced osteoporosis in inpatients recently discharged from a tertiary teaching hospital.
    Smith MD, Cheah SP, Taylor K, Ahern MJ.
    J Rheumatol; 2001 Mar 10; 28(3):566-70. PubMed ID: 11296960
    [Abstract] [Full Text] [Related]

  • 15. Management of bone loss in inflammatory bowel disease.
    Lichtenstein GR.
    Semin Gastrointest Dis; 2001 Oct 10; 12(4):275-83. PubMed ID: 11726081
    [Abstract] [Full Text] [Related]

  • 16. [Corticosteroid-induced osteoporosis].
    Trombetti A, Pennisi P, Rizzoli R.
    Rev Prat; 2004 Dec 15; 54(19):2132-7. PubMed ID: 15724591
    [Abstract] [Full Text] [Related]

  • 17. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A.
    Ann Acad Med Stetin; 2003 Dec 15; 49():111-30. PubMed ID: 15552843
    [Abstract] [Full Text] [Related]

  • 18. [Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors].
    Von Tirpitz C, Pischulti G, Klaus J, Rieber A, Brückel J, Böhm BO, Adler G, Reinshagen M.
    Z Gastroenterol; 1999 Jan 15; 37(1):5-12. PubMed ID: 10091278
    [Abstract] [Full Text] [Related]

  • 19. [Risk of osteoporosis in steroid therapy. When and how to counter the risk].
    Kirchgatterer A, Aschl G, Hinterreiter M, Knoflach P.
    MMW Fortschr Med; 2001 Jun 21; 143(25):37-9. PubMed ID: 11468995
    [Abstract] [Full Text] [Related]

  • 20. [Pharmacological prevention of osteoporosis in patients on corticosteroid medication].
    Lems WF, Jacobs JW, Netelenbos JC, Dijkmans BA, Bijlsma JW.
    Ned Tijdschr Geneeskd; 1998 Aug 22; 142(34):1904-8. PubMed ID: 9856175
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.